Shanta Gold's CEO explains the Q2 production shortfall and emphasises the cashflow strength of SGH. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8,480.00
Bid: 8,489.00
Ask: 8,491.00
Change: 21.00 (0.25%)
Spread: 2.00 (0.02%)
Open: 8,452.00
High: 8,525.00
Low: 8,440.00
Yest. Close: 8,459.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

AstraZeneca hails progress on chronic kidney disease with US approval

Mon, 3rd May 2021 07:58

(Alliance News) - Farxiga has been approved by the US Food & Drug Administration for treatment of chronic kidney disease, AstraZeneca PLC said late Friday.

The approval of Farxiga, whose generic name is dapagliflozin, "is the most significant advancement in the treatment of chronic kidney disease in more than 20 years," the Cambridge, England-based pharmaceutical firm said.

The US approval was based on positive results from the DAPA-CKD Phase III trial, AstraZeneca said, and follows the grant of a priority review by the FDA earlier this year.

The approval of Farxiga was for the reduction in the risk of sustained estimated glomerular filtration rate decline, end-stage kidney disease, cardiovascular death and hospitalisation for heart failure in adults with chronic kidney disease at risk of progression. Some 37 million people in the US have chronic kidney disease, Astra noted.

"Today's approval is the most significant advancement in the treatment of chronic kidney disease in more than 20 years," said Mene Pangalos, executive vice president of BioPharmaceuticals R&D at AstraZeneca. "We've shown impressive efficacy for Farxiga in type-2 diabetes, heart failure with reduced ejection fraction and, most recently, chronic kidney disease, and we are thrilled to be able to bring this medicine to millions of patients in the US."

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News

AstraZeneca's weekly-once diabetes drug gets U.S. approval for children

July 23 (Reuters) - AstraZeneca Plc said on Friday its diabetes drug Bydureon was approved in the United States for use in patients as young as age 10 to help reduce blood sugar levels along with diet and exercise.The drug, chemically called exena...

23 Jul 21 12:27

TOP NEWS: AstraZeneca vaccine effective after one dose, study shows

TOP NEWS: AstraZeneca vaccine effective after one dose, study shows

23 Jul 21 10:30

UPDATE 2-Vaccine business helps Lonza lifts 2021 sales outlook

* Sales and earnings beat forecasts during H1* Company raises sales guidance for full year* Plans to increase capex during H2 to raise production (Adds details, analyst comment, share price)By John RevillZURICH, July 23 (Reuters) - Swiss contract dr...

23 Jul 21 07:04

RPT-UPDATE 2-Vaccine business helps Lonza lifts 2021 sales outlook

(Repeats to fix formatting issues)* Sales and earnings beat forecasts during H1* Company raises sales guidance for full year* Plans to increase capex during H2 to raise productionBy John RevillZURICH, July 23 (Reuters) - Swiss contract drugmaker Lonz...

23 Jul 21 07:04

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

22 Jul 21 16:03

EXECUTIVE CHANGES: Nuformix responds to "frustration" as CEO departs

EXECUTIVE CHANGES: Nuformix responds to "frustration" as CEO departs

22 Jul 21 14:29

Two doses of Pfizer, AstraZeneca shots effective against Delta variant, study finds

LONDON, July 21 (Reuters) - Two doses of Pfizer or AstraZeneca's COVID-19 vaccine are nearly as effective against the highly transmissible Delta coronavirus variant as they are against the previously dominant Alpha variant, a study published on W...

21 Jul 21 22:00

AstraZeneca completes buy of rare diseases specialist Alexion

AstraZeneca completes buy of rare diseases specialist Alexion

21 Jul 21 16:48

CORRECT (Jul 19): Astra lung cancer treatment Imfinzi backed in China

CORRECT (Jul 19): Astra lung cancer treatment Imfinzi backed in China

20 Jul 21 15:16

Taiwan's Medigen to start late-stage clinical trial for COVID-19 vaccine in Paraguay

TAIPEI, July 20 (Reuters) - Taiwan's Medigen Vaccine Biologics Corp said on Tuesday it will start a late-stage clinical trial this year in Paraguay for its COVID-19 vaccine, part of the island's push to make its own shots against the coronavirus....

20 Jul 21 09:50

Jefferies believes Delta may be less lethal than other variants

(Sharecast News) - Analysts at Jefferies believe the so-called Delta variant may be less lethal, even if more transmissible, than earlier variants of the virus.

20 Jul 21 09:42

RPT-Leaked letters show AstraZeneca vaccine commitment not as Thailand claimed

(Repeats item first carried late on Monday)By Panu Wongcha-umBANGKOK, July 19 (Reuters) - AstraZeneca Plc has told Thailand it should be able to supply around 6 million doses of its COVID-19 vaccine per month, leaked correspondence showed, contrad...

20 Jul 21 01:24

UPDATE 1-Britain says most children will not be given COVID jabs

(Adds details)LONDON, July 19 (Reuters) - Britain said on Monday it has decided against giving mass COVID-19 vaccinations to all children and they would only be offered in certain situations such as when young people have underlying health conditi...

19 Jul 21 17:13

UK announces new exemptions to self-isolation rules for critical workers

LONDON, July 19 (Reuters) - Britain on Monday announced new exemptions to its rules on self-isolation for those exposed to COVID-19, saying that workers in critical roles could be allowed to continue working instead of quarantining for 10 days."We...

19 Jul 21 16:45

REFILE-UK announces new exemptions to self-isolation rules for critical workers

(Adds dropped letter in minister's name)LONDON, July 19 (Reuters) - Britain on Monday announced new exemptions to its rules on self-isolation for those exposed to COVID-19, saying that workers in critical roles could be allowed to continue working...

19 Jul 21 16:45

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.